Literature DB >> 20335432

High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.

Alessandra Mularoni1, Elisa Furfaro, Maura Faraci, Alessia Franceschi, Paola Mezzano, Roberto Bandettini, Claudio Viscoli, Elio Castagnola.   

Abstract

The plasmatic levels of 1,3-beta-d-glucan (BDG) were >523 pg/ml in 4 children, 2 low-birth-weight neonates and 2 stem cell transplant recipients, with the following invasive fungal diseases (IFD) proven apart from this BDG test: 3 cases of Candida parapsilosis candidemias and 1 case of disseminated aspergillosis. The BDG test may be useful for identification of IFD in pediatrics.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20335432      PMCID： PMC2863371          DOI： 10.1128/CVI.00038-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  17 in total

1.  Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.

Authors:  Daniel K Benjamin; Barbara J Stoll; Avory A Fanaroff; Scott A McDonald; William Oh; Rosemary D Higgins; Shahnaz Duara; Kenneth Poole; Abbot Laptook; Ronald Goldberg
Journal:  Pediatrics       Date:  2006-01       Impact factor: 7.124

Review 2.  Non-culture-based diagnostics for opportunistic fungi.

Authors:  Monique A S H Mennink-Kersten; Paul E Verweij
Journal:  Infect Dis Clin North Am       Date:  2006-09       Impact factor: 5.982

3.  Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation.

Authors:  E Castagnola; E Furfaro; I Caviglia; M Licciardello; M Faraci; F Fioredda; P Tomà; R Bandettini; M Machetti; C Viscoli
Journal:  Clin Microbiol Infect       Date:  2010-02-11       Impact factor: 8.067

4.  Fungal infections in children with cancer: a prospective, multicenter surveillance study.

Authors:  Elio Castagnola; Simone Cesaro; Mareva Giacchino; Susanna Livadiotti; Fabio Tucci; Giulio Zanazzo; Desirè Caselli; Ilaria Caviglia; Stefano Parodi; Roberto Rondelli; Pier Emilo Cornelli; Rossella Mura; Nicola Santoro; Giovanna Russo; Raffaella De Santis; Salvatore Buffardi; Claudio Viscoli; Riccardo Haupt; Mario R Rossi
Journal:  Pediatr Infect Dis J       Date:  2006-07       Impact factor: 2.129

5.  Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

Authors:  Luis Ostrosky-Zeichner; Barbara D Alexander; Daniel H Kett; Jose Vazquez; Peter G Pappas; Fumihiro Saeki; Paul A Ketchum; John Wingard; Robert Schiff; Hiroshi Tamura; Malcolm A Finkelman; John H Rex
Journal:  Clin Infect Dis       Date:  2005-07-21       Impact factor: 9.079

6.  Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study.

Authors:  A Sulahian; F Boutboul; P Ribaud; T Leblanc; C Lacroix; F Derouin
Journal:  Cancer       Date:  2001-01-15       Impact factor: 6.860

7.  Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.

Authors:  Christopher D Pfeiffer; Jason P Fine; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2006-04-14       Impact factor: 9.079

8.  Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients.

Authors:  William J Steinbach; Rachel M Addison; Lisa McLaughlin; Quincy Gerrald; Paul L Martin; Timothy Driscoll; Christopher Bentsen; John R Perfect; Barbara D Alexander
Journal:  Pediatr Infect Dis J       Date:  2007-07       Impact factor: 2.129

9.  Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Zekaver Odabasi; Gloria Mattiuzzi; Elihu Estey; Hagop Kantarjian; Fumihiro Saeki; Richard J Ridge; Paul A Ketchum; Malcolm A Finkelman; John H Rex; Luis Ostrosky-Zeichner
Journal:  Clin Infect Dis       Date:  2004-06-28       Impact factor: 9.079

10.  Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.

Authors:  P Brian Smith; Daniel K Benjamin; Barbara D Alexander; Melissa D Johnson; Malcolm A Finkelman; William J Steinbach
Journal:  Clin Vaccine Immunol       Date:  2007-05-30
View more
  19 in total

1.  Elevated serum beta-D-glucan levels in immunocompromised children with clinical suspicion for Pneumocystis jirovecii pneumonia.

Authors:  Blanca E Gonzalez; Luis A Faverio; Francisco M Marty; Craig MacArthur; Robin B Churchill
Journal:  Clin Vaccine Immunol       Date:  2011-05-04

2.  The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in Children.

Authors:  Brian T Fisher
Journal:  Curr Fungal Infect Rep       Date:  2013-03-01

3.  Persistence of high-level (1,3)-β-D-glucan after candidemia following autologous peripheral SCT in a pediatric patient.

Authors:  A Naselli; M Faraci; E Lanino; G Morreale; G Cangemi; R Bandettini; E Castagnola
Journal:  Bone Marrow Transplant       Date:  2014-09-22       Impact factor: 5.483

4.  The diagnostic performance of the beta-glucan assay in the detection of intra-amniotic infection with Candida species.

Authors:  Percy Pacora; Roberto Romero; Offer Erez; Eli Maymon; Bogdan Panaitescu; Juan Pedro Kusanovic; Adi L Tarca; Chaur-Dong Hsu; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-12-27

Review 5.  Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.

Authors:  Anna R Huppler; Brian T Fisher; Thomas Lehrnbecher; Thomas J Walsh; William J Steinbach
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

6.  The role of procalcitonin in neonatal intensive care unit patients with candidemia.

Authors:  Maria Teresa Montagna; Caterina Coretti; Antonella Rella; Giovanna Barbuti; Fabio Manca; Osvaldo Montagna; Nicola Laforgia; Giuseppina Caggiano
Journal:  Folia Microbiol (Praha)       Date:  2012-06-12       Impact factor: 2.099

7.  Case report of the reliability 1,3-β-D-glucan monitoring during treatment of peritoneal candidiasis in a child receiving continuous peritoneal dialysis.

Authors:  Francesca Ginocchio; Enrico Verrina; Elisa Furfaro; Rossella Cannavò; Roberto Bandettini; Elio Castagnola
Journal:  Clin Vaccine Immunol       Date:  2012-02-22

8.  (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients.

Authors:  Christine M Salvatore; Tempe K Chen; Sima S Toussi; Patricia DeLaMora; Ruta Petraitiene; Malcolm A Finkelman; Thomas J Walsh
Journal:  J Pediatric Infect Dis Soc       Date:  2015-03-19       Impact factor: 3.164

9.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

Review 10.  The epidemiology and diagnosis of invasive candidiasis among premature infants.

Authors:  Matthew S Kelly; Daniel K Benjamin; P Brian Smith
Journal:  Clin Perinatol       Date:  2014-11-28       Impact factor: 2.642
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.